I. Introduction
MS (syndrome X, insulin-resistant syndrome, dysmorphic metabolic syndrome and revean syndrome) is very common clinical condition and one of the major health public challenges due to its association with cardiovascular morbidity and mortality as well as complication of Diabetic Mellitus (DM) [1] . MS definition by the recent National Cholesterol Education Program (NCEP) and Adult Treatment Panel (ATP) III required three of the following abnormalities: waist circumference > 88 cm for women and > 102 for men; fasting serum triglyceride > 1.7 mmol/ L (150 mg/dL) and HDL Cholesterol < 1 mmol/ L (40 mg/ dL) for men and < 1.3 mmol/ L (50 mg/ dL) for women; blood pressure > 130/ 85 mmHg (or history of hypertension), or fasting blood sugar (FBS) > 5.7 mmol/ L (100 mg/ dL) b [2] . There is another definition of MS according to the World Health Organization (WHO) includes either impaired FBS > 6.1 mmol/ L (110 mg/ dL) or hyperinsulinemia plus two of the following: abdominal obesity (waist to hip ratio > 0.9, Body Mass Index (BMI) ≥ 30 kg/ m 2 , waist girth > 94 cm); dyslipidemia (triglyceride > 150 mg/ dL or HDL < 40 mg/ dL in men and < 50 mg/ dL in women); hypertension (blood pressure 130/ 85 mmHg); microalbuminurea (30-300 mg/ dL) [3] . However, many authorities especially in last few years depend on NCEP-ATP III for definition of MS rather that of WHO criteria, because of accuracy, applicability and specificity of the former definition. The major determinant of MS is insulin resistance with resultant hyperinsulinemia which is the cause of type 2 DM [4] . Greater researchesworldwide have been associated with increased rate of obesity, which is anticipated to dramatically increase prevalence of MS. The highest recorded prevalence was in Native America with nearly (60%) for women aged 45-49 years and (45%) for men aged 45-49 years according to NCEP and ATP III, meanwhile, it is (22%) for women aged 45-49 years and (19.5%) for men aged 45-49 years which is the lowest by the former record [5] . The pathogenesis of MS is still unclear despite of some risk factors which interact to cause this syndrome. Many components of MS have been associated with sedentary lifestyle including increase central adipose tissues, reduce HDL and a trend towards increase triglyceride, high blood pressure as well as glucose. So far, central obesity is one of the main causes of MS, which is responsible for insulin resistance at peripheral tissues [6] . Grundy et al, 2005 reported in their study, MS is age dependent and associated with high prevalence worldwide [7] . In 2004, Popkin and Gordon-Larsen revealed increase prevalence of MS in type 2 diabetic patients or in those with impaired glucose tolerance (IGT).
Recently Fauci and his team attributed the pathogenesis of MS to Free Fatty Acids (FFAs) which is an expanded adipose tissue. FFAs results in an increase production of liver glucose, triglyceride as well as liver secretion of VLDL. Meanwhile, FFAs in periphery cause highLDL, low HDL as well as low peripheral insulin sensitivity [8] . The term MS refersto the clustering of a number of cardiovascularrisk factors (obesity, hypertension,dyslipidemia, and hyperglycemia)believed to be related to insulin resistance.It is estimated that about 20-25% of theworld's adult population have MS, and they are twice as likely todie of and three times as likely to have aheart attack or stroke compared with peoplewithout MS. In addition,people with MS have afivefold greater risk of developing type 2 DM [9] .Despite of highly prevalence for patients with type 2 DM, hypertension, dyslipedimia as well as sedentary lifestyle, the information about the prevalence of MS in Al-Hilla City is still lacked. This study has been carried out to determine the proportion of MS among patients with type 2 DM and its association with MS risk factors at Merjan Teaching Hospital in Al-Hilla City.
II. Materials And Methods

Study design/Study Location
This hospital-based cross-sectional study was carried out in a tertiary centre (diabetic outpatient clinic in Merjan Teaching Hospital).
Study population
All patients with diagnosed type 2 DM seen at the diabetic outpatient clinic in Merjan Teaching Hospital between December 2011 and December 2012 were included in this study.
Instruments and procedures
The outcome variable was the Metabolic Syndrome (absence or presence), meanwhile, the independent variables wereage, sex, residence, waist circumference, Body Mass Index (BMI), triglyceride, HDL, sedentary life style and presence of hypertension.
Blood Pressure Measurement
Blood pressure has been measured using mercury sphygmomanometer (used for all patients who are not diagnosed previously), while the patients sitting for five minutes. The cut off was equal ≥ 130/ 85 mmHg according to the NCEP or ATP III and did not depend on WHO criteria for diagnosis of hypertension.
Abdominal Obesity
NCEP or ATP III was the depending criteria to measure the waist circumference and determining abdominal obesity. A waist circumference of > 102 cm for male and > 88 cm for female have been obtained while the patient was standing up and the measurement at the level of umbilicus as the smallest girth between the costal margin and the iliac crests.
Biochemical Estimation
After a minimum of six fasting hours, five millilitres of venous blood was drawn from the antecubital vein of each participant. Separation was done using a centrifuge at 3000 round/ minute for about 15 minutes, the high density lipoprotein cholesterol (HDL-C) fraction was measured after precipitation of LDL-C and VLDL-C with dextran sulphate magnesium technique. Triglyceride estimation was measured by the enzymatic method. Accuracy was mentioned using commercial-quality control sera. The diagnosis of MS wasconfirmed by obtaining the measurements of FBS, waist circumference, triglyceride, HDL-C and blood pressure. According to ATP III criteria, patient who have three or more of the following criteria will defined as having MS: Abdominal obesity (> 102 and > 88 cm for men and women, respectively), hypertriglyceridemia (> 1.7 mmol/ L), low HDL-C (< 1 and < 1.2 mmol/L for men and women, respectively) as well as blood pressure of (> 130/ 85 mmHg).
Statistical Analysis
Statistical analysis was carried out using SPSS version 18. Categorical variables were presented as frequencies and percentages. Continuous variables were presented as means with their 95% confidence interval (CI). The Pearson's chi-square test (x 2 ) test was used to determine the associations between categorical variables. Independent sample t-test was used to compare means between two groups.Binary Logistic regression was done for multivariate analysis. A p-value of ≤ 0.05 was considered as statistically significant.
III.
Results
Out of 300 patients with type 2 DM, 226 (75.3%) had with MS( Figure 1 ). The overall mean age of patients was 57.26± 7.07 years. Meanwhile, the mean age of diabetic patients with MS was 57.53± 6.99 years. There was significant differences of mean age for male 58.60± 6.30 years and female 55.70± 7.01 years (t= 3.649, df =298 and p <0.001), (66.7%) of male patients were aged ≥ 60 years ( Figure 2 ). (45.7%) ofpatients were from urban area ( Figure 3 ). Figure 4 shows that, (73.3%) of women were obese. Table 2 shows the association of metabolic syndrome and patient's socio-demographic characteristics. There were significant association between metabolic syndrome with sex and residence, meanwhile there was no significant association between metabolic syndrome and age. Table 3 shows the association of metabolic syndrome with its risk factors. There were significant association between metabolic syndrome with abdominal obesity, life style, triglyceride, HDL and blood pressure. Table 5 shows the logistic regression. Only eight independent variables showed significant contribution to the model (sex, residence, abdominal obesity, lifestyle, triglyceride and hypertension). The strongest predictor of reporting MS was triglyceride. Diabetic patients with high triglyceride were71 times more likely to report MS than those with normal triglyceride. Patients from urban area, adapted sedentary life style female sex, hypertensive and obese patients were 15, 12, 6 as well as 5 times more likely to report MS than other patients. 
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Discussion
MS is increasing in prevalence, paralleling an increasing epidemic of obesity. In the United States, more than one fourth of the population meets diagnostic criteria for MS which is approximately the same prevalence forEuropean population and Latin America [10] .Meanwhile,the prevalence of MS in East Asia may range from 8-13% in men and from 2-18% in women, depending on the population and definitions used [11] [12] [13] [14] .Many reports have been published on the prevalence of the MS in the Middle East. A community-based, cross-sectional survey in Basrah (Iraq) reported the optimal cutoff point of waist circumference for the diagnosis of MS as 99 cm in women and 97 cm in men [15] [16] [17] .However, a larger study on the prevalence of MS in the Middle East have been conducted in Iran, the age-standardized prevalence of the MS was about 34.7% and 37.4% based on the ATP III and IDF definition, respectively [18] .Meanwhile, a multinational study from 65 centers in six Middle Eastern countries (Bahrain, Kuwait, Qatar, Oman, United Arab Emirates, and Yemen) evaluated the prevalence and effect of MS based on IDF diagnostic criteria. MS was highly prevalent among patients presenting with acute coronary syndrome [19] . Furthermore, in a nationwide study in Egypt,central obesity was estimated in the study to be 29% with a more prevalence in women [20] . In addition Turkey survey according to ATP III guideline reported a prevalence of 33.9% for MS, with a higher prevalence in women (39.6%) than in men (28%) [21] . The present study had been carried out to determine the presence as well as the components of MS for patients with type 2 DM at diabetic outpatient clinic inMerjan Teaching Hospital Al-Hilla City. According to NECP and ATP III criteria that had been depended in this study, the proportion of MS was 75.3% among type 2 DM patients,however, there are differences between this finding and other findings by western countries attributed to the societies, lifestyles and races differences. In this study, women were more than men to develop MS, however, majority of women in current study were obese (Figure 4 ) as well as adapted lower level of physical activities and higher calories food. Furthermore, these findings were in agreement with other local, regional as well as global studies [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] .Meanwhile, this study was not in agreement with Finish study which reported that the prevalence of MS was higher among men than women due to higher men waist to hip ratio than women [25] . Patients from urban area were 15 times more likely to develop MS, however, these finding have been attributed to adapt sedentary lifestyle, physical inactivity as well as unhealthy food habits of people from urban area as reported in regional studies of Turkey, Iran and other studies [24,26 and 27] .Majority (69.9%) of diabetic patients with MS in current study were obese, on other hand, those obese diabetic patients were five times more likely to develop MS. These finding were in agreement with Singaporean cohort study on central obesity in 2007, who revealed that central obesity could be as optional component of MS according to International Diabetes Federation (IDF), but these patients with central obesity were at a higher risk to develop Ischemic Heart Diseases (IHD) [12-19 and 28] . Although hypertension is one of components that may be involved in diagnosis of MS, diabetic patients with hypertension in this study were six times more likely to develop MS. However, adapting poor lifestyle and food habit as well as highly elevated fasting triglyceride by patients lead to poorly controlled blood pressure [28] . Patients withhighly triglyceride level were the strongest predictor to develop MS in this study, patients with high triglyceride were 71 times more likely to develop MS than patients with normal triglyceride.Hypertriglyceridemia commonly occurs along withother components of the metabolic syndrome [29] . Anelevated triglyceride is the most availablelaboratory marker to uncover the coexistence of multiplerisk factors, including non-lipid risk factors, suchas hypertension [29 and 30] , elevated plasma glucose, and a prothromboticstate [29] . Hypertriglyceridemic patients thusmust be carefully evaluated for the other metabolicrisk factors that occur with the metabolic syndrome.Any patient whose triglyceride concentrations exceed150 mg/dL is suspect for the metabolic syndrome [29] [30] [31] .Elevated serum triglycerides commonlyassociate with insulin resistance and represent avaluable clinical marker of the metabolic syndrome. The connections between insulin resistanceand atherogenicdyslipidemia, hypertension, a prothromboticstate, and glucose intolerance are complexand may be mediated through multiple metabolicpathways.
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Conclusion
Developing countries are undergoing an epidemiologic transition accompanied by increasing burden of CVD linked to urbanization and lifestyle modifications. MS is a cluster of CVD risk factors whose extent remains unknown. Among all the patients with type 2 DM have been received at outpatientsdiabetic clinic in Merjan Teaching Hospital from December 2011 to December 2012, the proportion of MS was (75.3%). Diabetic patients with high triglyceride were71 more likely to developMS, followed by patients from urban area, sedentary lifestyle, female patients and patients with hypertension as well as abdominal obesity. However, there were no significant association between MS and age. This study has been provided appropriate data for MS in Al-Hilla City as well as a proper prediction of the main risk factors that highly associated with development of MS.
